Trials / Unknown
UnknownNCT00661648
Effect of an Artificial Pancreas in Patients Undergoing Pancreatic Resection
Prevention for Surgical Site Infection After Pancreatic Resection
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Kochi University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study evaluated that strict control of perioperative blood glucose following pancreatic resection by using an artificial pancreas would improve postoperative surgical site infection.
Detailed description
This study recruited 50 patients undergoing elective pancreatic resection for pancreatic diseases. Perioperative blood glucose concentration was continuously monitored using an artificial pancreas system. We prospectively divided into two groups: one for whom glucose levels were controlled using a manual injection of insulin according to the commonly used sliding scale and another that received programmed infusion of insulin determined by the control algorithm of the artificial pancreas.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | the closed-loop STG-22 system (Nikkiso Inc, Tokyo, Japan) | artificial pancreas |
Timeline
- Start date
- 2007-04-01
- Primary completion
- 2009-04-01
- Completion
- 2009-06-01
- First posted
- 2008-04-18
- Last updated
- 2009-01-29
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT00661648. Inclusion in this directory is not an endorsement.